 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - MADRIGAL PHARMACEUTICALS Inc (MDGL)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2018-11-19 Sale | 2020-02-26 6:06 pm | MADRIGAL PHARMACEUTICALS Inc | MDGL | MILLIGAN DAVID V Director | 10,000 | $131.6 | $1,316,000 | 20,000 (Direct) | View |
| 2018-11-21 Sale | 2020-02-26 5:41 pm | MADRIGAL PHARMACEUTICALS Inc | MDGL | MILLIGAN DAVID V Director | 20,000 | $112.5 | $2,250,800 | 0 (Direct) | View |
| 2019-12-13 Sale | 2019-12-13 2:18 pm | MADRIGAL PHARMACEUTICALS Inc | MDGL | BAY CITY CAPITAL LLC Bay City Capital Management IV LLC Bay City Capital Fund IV L.P. BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP 10% Owner | 1,200,000 | $105.5 | $126,564,001 | 88,152 (Indirect) | View |
| 2019-12-13 Sale | 2019-12-13 2:08 pm | MADRIGAL PHARMACEUTICALS Inc | MDGL | CRAVES FRED B Director 10% Owner | 1,200,000 | $105.5 | $126,564,001 | 88,152 (Indirect) | View |
| 2018-06-11 Sale(A) | 2019-12-13 1:41 pm | MADRIGAL PHARMACEUTICALS Inc | MDGL | CRAVES FRED B Director 10% Owner | 5,908 | $287.5 | $1,698,314 | 113,472 (Indirect) | View |
| 2018-11-20 Purchase | 2018-11-23 8:53 pm | MADRIGAL PHARMACEUTICALS Inc | MDGL | FRIEDMAN PAUL A CEO | 4,000 | $117.9 | $471,520 | 161,128 (Direct) | View |
| 2018-11-19 Purchase | 2018-11-19 6:26 pm | MADRIGAL PHARMACEUTICALS Inc | MDGL | FRIEDMAN PAUL A CEO | 4,000 | $124 | $496,000 | 157,128 (Direct) | View |
| 2018-11-19 Purchase | 2018-11-19 6:09 pm | MADRIGAL PHARMACEUTICALS Inc | MDGL | CRAVES FRED B Director 10% Owner | 2,000 | $124.7 | $249,387 | 298,067 (Direct) | View |
| 2018-06-11 Sale | 2018-06-13 3:53 pm | MADRIGAL PHARMACEUTICALS Inc | MDGL | Schneebaum Marc R CFO | 10,099 | $287.5 | $2,903,058 | 41,668 (Direct) | View |
| 2018-06-11 Sale | 2018-06-12 9:02 pm | MADRIGAL PHARMACEUTICALS Inc | MDGL | CRAVES FRED B Director 10% Owner | 280,000 | $287.5 | $80,488,798 | 113,472 (Indirect) | View |
| 2018-06-11 Sale | 2018-06-12 8:56 pm | MADRIGAL PHARMACEUTICALS Inc | MDGL | FRIEDMAN PAUL A CEO | 73,526 | $287.5 | $21,135,783 | 655,540 (Indirect) | View |
| 2018-06-11 Sale | 2018-06-12 8:55 pm | MADRIGAL PHARMACEUTICALS Inc | MDGL | Taub Rebecca Chief Medical Officer EVP R&D | 73,526 | $287.5 | $21,135,783 | 655,540 (Indirect) | View |
| 2018-06-11 Sale | 2018-06-12 8:50 pm | MADRIGAL PHARMACEUTICALS Inc | MDGL | BAY CITY CAPITAL LLC Director 10% Owner | 280,000 | $287.5 | $80,488,798 | 113,472 (Indirect) | View |
| 2017-08-23 Purchase | 2017-08-24 4:04 pm | MADRIGAL PHARMACEUTICALS Inc | MDGL | Levy Richard S Director | 2,000 | $16.12 | $32,236 | 9,100 (Direct) | View |
| 2017-08-22 Purchase | 2017-08-23 4:03 pm | MADRIGAL PHARMACEUTICALS Inc | MDGL | Levy Richard S Director | 3,550 | $16.12 | $57,209 | 7,100 (Direct) | View |
| 2017-08-21 Purchase | 2017-08-22 4:05 pm | MADRIGAL PHARMACEUTICALS Inc | MDGL | Levy Richard S Director | 3,550 | $15.88 | $56,358 | 3,550 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2020-03-05 Option Award | 2020-03-05 5:05 pm | N/A 2030-03-05 | MADRIGAL PHARMACEUTICALS Inc | MDGL | Lynch Brian Joseph VP | 32,000 | $91.79 | 32,000 (Direct) | View |
| 2020-03-05 Option Award | 2020-03-05 5:04 pm | N/A 2030-03-05 | MADRIGAL PHARMACEUTICALS Inc | MDGL | FRIEDMAN PAUL A CEO | 50,000 | $91.79 | 50,000 (Direct) | View |
| 2020-03-05 Option Award | 2020-03-05 5:02 pm | N/A 2030-03-05 | MADRIGAL PHARMACEUTICALS Inc | MDGL | Taub Rebecca Pres. R&D and CMO | 44,000 | $91.79 | 44,000 (Direct) | View |
| 2020-03-05 Option Award | 2020-03-05 5:02 pm | N/A 2030-03-05 | MADRIGAL PHARMACEUTICALS Inc | MDGL | Schneebaum Marc R CFO | 32,000 | $91.79 | 32,000 (Direct) | View |
| 2019-07-10 Option Award | 2019-07-11 11:28 am | N/A 2029-07-10 | MADRIGAL PHARMACEUTICALS Inc | MDGL | Taub Rebecca President | 8,000 | $101.3 | 8,000 (Direct) | View |
| 2019-06-27 Option Award | 2019-07-01 5:59 pm | N/A 2024-06-27 | MADRIGAL PHARMACEUTICALS Inc | MDGL | Levy Richard S Director | 10,000 | $100.4 | 10,000 (Direct) | View |
| 2019-06-27 Option Award | 2019-07-01 5:58 pm | N/A 2024-06-27 | MADRIGAL PHARMACEUTICALS Inc | MDGL | BATE KENNETH Director | 10,000 | $100.4 | 10,000 (Direct) | View |
| 2019-06-27 Option Award | 2019-07-01 5:55 pm | N/A 2024-06-27 | MADRIGAL PHARMACEUTICALS Inc | MDGL | Daly James M Director | 20,000 | $100.4 | 20,000 (Direct) | View |
| 2019-06-27 Option Award | 2019-07-01 5:47 pm | N/A 2024-06-27 | MADRIGAL PHARMACEUTICALS Inc | MDGL | CRAVES FRED B Director 10% Owner | 10,000 | $100.4 | 10,000 (Direct) | View |
| 2019-06-27 Option Award | 2019-07-01 5:39 pm | N/A 2024-06-27 | MADRIGAL PHARMACEUTICALS Inc | MDGL | Gollust Keith R Director | 10,000 | $100.4 | 10,000 (Direct) | View |
| 2019-06-27 Option Award | 2019-07-01 5:13 pm | N/A 2024-06-27 | MADRIGAL PHARMACEUTICALS Inc | MDGL | MILLIGAN DAVID V Director | 10,000 | $100.4 | 10,000 (Direct) | View |
| 2019-03-07 Option Award | 2019-03-11 3:42 pm | N/A 2029-03-07 | MADRIGAL PHARMACEUTICALS Inc | MDGL | Taub Rebecca Chief Medical Officer EVP R&D | 38,000 | $128 | 38,000 (Direct) | View |
| 2019-03-07 Option Award | 2019-03-11 3:42 pm | N/A 2029-03-07 | MADRIGAL PHARMACEUTICALS Inc | MDGL | FRIEDMAN PAUL A CEO | 50,000 | $128 | 50,000 (Direct) | View |
| 2019-03-07 Option Award | 2019-03-11 3:41 pm | N/A 2029-03-07 | MADRIGAL PHARMACEUTICALS Inc | MDGL | Schneebaum Marc R CFO | 28,000 | $128 | 28,000 (Direct) | View |
| 2018-11-14 Exercise | 2018-11-14 6:43 pm | N/A N/A | MADRIGAL PHARMACEUTICALS Inc | MDGL | MILLIGAN DAVID V Director | 10,000 | $16.46 | 0 (Direct) | View |
| 2018-11-14 Exercise | 2018-11-14 6:43 pm | 2018-06-29 2027-06-29 | MADRIGAL PHARMACEUTICALS Inc | MDGL | MILLIGAN DAVID V Director | 10,000 | $16.46 | 0 (Direct) | View |
| 2018-09-18 Exercise | 2018-09-19 4:25 pm | N/A N/A | MADRIGAL PHARMACEUTICALS Inc | MDGL | MILLIGAN DAVID V Director | 20,000 | $9.45 | 0 (Direct) | View |
| 2018-09-18 Exercise | 2018-09-19 4:25 pm | 2017-07-22 2026-07-22 | MADRIGAL PHARMACEUTICALS Inc | MDGL | MILLIGAN DAVID V Director | 20,000 | $9.45 | 0 (Direct) | View |
| 2018-06-19 Option Award | 2018-06-21 8:52 pm | N/A 2028-06-19 | MADRIGAL PHARMACEUTICALS Inc | MDGL | BATE KENNETH Director | 10,000 | $303.8 | 10,000 (Direct) | View |
| 2018-06-19 Option Award | 2018-06-21 7:03 pm | N/A 2028-06-19 | MADRIGAL PHARMACEUTICALS Inc | MDGL | Levy Richard S Director | 10,000 | $303.8 | 10,000 (Direct) | View |
| 2018-06-19 Option Award | 2018-06-21 7:00 pm | N/A 2028-06-19 | MADRIGAL PHARMACEUTICALS Inc | MDGL | MILLIGAN DAVID V Director | 10,000 | $303.8 | 10,000 (Direct) | View |
| 2018-06-19 Option Award | 2018-06-21 7:00 pm | N/A 2028-06-19 | MADRIGAL PHARMACEUTICALS Inc | MDGL | Gollust Keith R Director | 10,000 | $303.8 | 10,000 (Direct) | View |
| 2018-06-19 Option Award | 2018-06-21 7:00 pm | N/A 2028-06-19 | MADRIGAL PHARMACEUTICALS Inc | MDGL | CRAVES FRED B Director 10% Owner | 10,000 | $303.8 | 10,000 (Direct) | View |
| 2018-06-11 Exercise | 2018-06-13 3:53 pm | N/A N/A | MADRIGAL PHARMACEUTICALS Inc | MDGL | Schneebaum Marc R CFO | 5,223 | $99.75 | 41,668 (Direct) | View |
| 2018-06-11 Exercise | 2018-06-13 3:53 pm | N/A N/A | MADRIGAL PHARMACEUTICALS Inc | MDGL | Schneebaum Marc R CFO | 2,734 | $61.6 | 41,668 (Direct) | View |
| 2018-06-11 Exercise | 2018-06-13 3:53 pm | 2015-12-08 2024-12-08 | MADRIGAL PHARMACEUTICALS Inc | MDGL | Schneebaum Marc R CFO | 5,223 | $99.75 | 41,668 (Direct) | View |
| 2018-06-11 Exercise | 2018-06-13 3:53 pm | 2016-10-02 2025-10-02 | MADRIGAL PHARMACEUTICALS Inc | MDGL | Schneebaum Marc R CFO | 2,734 | $61.6 | 41,668 (Direct) | View |
| 2018-03-01 Option Award | 2018-03-05 12:47 pm | N/A 2028-03-01 | MADRIGAL PHARMACEUTICALS Inc | MDGL | Schneebaum Marc R CFO | 28,000 | $124.4 | 28,000 (Direct) | View |
| 2018-03-01 Option Award | 2018-03-05 12:47 pm | N/A 2028-03-01 | MADRIGAL PHARMACEUTICALS Inc | MDGL | Taub Rebecca Chief Medical Officer EVP R&D 10% Owner | 38,000 | $124.4 | 38,000 (Direct) | View |
| 2018-03-01 Option Award | 2018-03-05 12:46 pm | N/A 2028-03-01 | MADRIGAL PHARMACEUTICALS Inc | MDGL | FRIEDMAN PAUL A CEO | 50,000 | $124.4 | 50,000 (Direct) | View |